1887
Rapid communications Open Access
Like 0

Abstract

We describe the second case in Europe of verified treatment failure of pharyngeal gonorrhoea, caused by an internationally occurring multidrug-resistant gonococcal clone, with recommended first-line ceftriaxone 250 mg in Slovenia. This is of grave concern since ceftriaxone is last remaining option for empirical treatment. Increased awareness of ceftriaxone failures, more frequent test-of-cure, strict adherence to regularly updated treatment guidelines, and thorough verification/falsification of suspected treatment failures are essential globally. New effective treatment options are imperative.

Loading

Article metrics loading...

/content/10.2807/ese.17.25.20200-en
2012-06-21
2017-11-19
http://instance.metastore.ingenta.com/content/10.2807/ese.17.25.20200-en
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/17/25/art20200-en.htm?itemId=/content/10.2807/ese.17.25.20200-en&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error